Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 35 Biotech Angel Investors in Canada

Last updated: Apr 2024 A list of 35 angel investors that invest in Biotech startups based in Canada. We rank investors based on the number of investments they made in Biotech companies from Canada. We update this investor list every month.

Top 35 Biotech Angel Investors in Canada

Investor	Biotech Canada investments
Bootstrapped Debt Financing	3
Ray Muzyka	2
Tom Williams	2
Ajay Agrawal	2
T. Chen Fong	2
Noel Hall	2
Ajay Agrawal	2
Jacky Chen	1
Claudette McGowan	1
Greg Wolfond	1
Lee Lau	1
Ran Tuttnauer	1
Paul Buchheit	1
Dan Schultz	1
Milad Alucozai	1
Nilesh Bansal	1
Frederic Ors	1
Haig Farris	1
Sandra MacPherson	1
Dennis Bennie	1
bumpkins profile	1
Amarjit Gill	1
Lip-Bu Tan	1
Nick Koudas	1
Lawrence Bloch	1
Jed McCaleb	1
Wei Guo	1
Ryan Pawell	1
Daniel Debow	1
Jeff Mallett	1
Collin Terpstra	1
Jon Oringer	1
Rami Essaid	1
Shaz Khan	1
Carol Leaman	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Bootstrapped Debt Financing

Investment focus

Software, Information Technology, E-Commerce
Pre-Seed, Seed, Funding Round
United States, Canada, United Kingdom

Portfolio highlights

Kornem Energy — Kornem Energy provides energy intelligence and mobile-fuel delivery and diesel delivery on demand for the needs of today, tomorrow, and our future.We are eliminating the traditional fuel supply chain infrastructure using IOT & a compact terminal-to-car logistics aggregation, through service, automation and mobility.This enables us todeliver fuel directly to the customers who can request fuel delivery wherever they are, through our mobile app, while bridging the gap between feedstock aggregation, quality-assurance and end-user accessibility.No more expensive real estate, no more extensive supply chain. Just #FuelToYou
SymbaSync — SymbaSync™ helps organizations maximize return on employee investment by providing Human Resources Software to source, qualify, and engage employees to populate project teams. SymbaSync’s tools increase employee satisfaction improving employee ownership, engagement, and retention. SymbaSync provides a company with a complete overview of up-to-dateemployee skills, interests, and workplace preferences.
Tactii — We do rapid prototyping on machine learning and analytics for small companies. Our main focus is to bring down the budget for small companies and startups who want to explore things in Machine Learning. Affordable Machine Learning for startups and small companies. We are partnering up with various startups and small companies.

Originally trained as a medical doctor, Dr. Ray Muzyka cofounded BioWare, a video game development studio focusing on story and character, in the early 1990s. He practiced emergency/family medicine for two years full time, with medicine transitioning to part-time over the following decade as he focused on his role as BioWare’s CEO. BioWare wasacquired by Electronic Arts in 2007, and Dr. Muzyka took on the roles of Senior Vice President at Electronic Arts and General Manager of EA’s BioWare division, which grew over the next five years to span eight development locations worldwide with about 2000 staff (1400 full time). He retired from video games in October 2012, with his third “career chapter” at ThresholdImpact, where he focused on sustainable, profitable impact investing: mentoring and angel investing in information technology, new media, and medical innovations with social entrepreneurs. An active angel investor and entrepreneurial mentor, Dr. Muzyka is a member of the Young Presidents’ Organization, the A100, the Ashoka Support Network, and the Board of Governors of the University of Alberta (serving as Chair of the Human Resources Committee and on the Learning and Discovery Committee and as a member of the University of Alberta Advancement Council). He is Chair of the University of Alberta’s entrepreneur Venture Mentoring Service, a venture advisor at iNovia Venture Capital, and a member of the Alberta Research and Innovation Advisory Committee and the Alberta Premier’s Advisory Committee on the Economy. He also serves on a number of private company boards. He previously served on the board of the Academy of Interactive Arts and Sciences from 2001-2008 and was on the Board of Trustees of the Stollery Children’s Health Foundation from 2012-2015. He was inducted into the Academy of Interactive Arts and Sciences’ Hall of Fame in 2011 and received the International Game Developers’ Choice Awards 2013 Lifetime Achievement Award. Dr. Muzyka received the inaugural Alumni Innovation Award in 2015 from the University of Alberta. He additionally was named as the 2017 Allard Chair in Business at the MacEwan University’s School of Business and as an Honorary Paul Harris Fellow by Rotary Club International in 2016, in recognition for his philanthropic efforts. Other awards include entry into Canada’s Top 40 under 40 and Ernst and Young’s 2001 Entrepreneur of the Year (IT, Prairies).He obtained his Bachelor of Medical Science from the University of Alberta in 1990, his Doctorate of Medicine from there in 1992, and his MBA from the University of Western Ontario (Ivey School of Business) in 2001.

Investment focus

Health Care, Software, Information Technology
Seed, Pre-Seed, Funding Round
Canada, United States

Portfolio highlights

Leadoptik — Leadoptik is a California-based company is currently operating in stealth mode.
Modality.AI, Inc. — Modality.ai is an AI-powered platform that detects health conditions using conversational AI. Through dialogue and video, Modality.AI interacts conversationally with the patient to provide health assessment anywhere, anytime. Its system analyzes multimodal data which allows continuous screening and assessing of patients’ health.
Gray Oncology Solutions — Gray Oncology Solution is a healthcare enterprise software company that commercializes GrayOS, the operating system for oncology.

Tom Williams

Investment focus

Software, Health Care, Financial Services
Seed, Series A, Series B
United States, Canada, India

Portfolio highlights

Unito — Discover 2-way integrations to empower your digital organization to sync securely in under 12 minutes with a no-code solution.
Delphia — Invest with your data, not your money.
NorthOne — NorthOne is an online Business Account with built-in features to make business banking fast and easy. No overdraft fees. No minimum balance. No hidden fees.

Ajay Agrawal is the Co-Founder of Sanctuary Cognitive Systems Corporation. He previously worked at Queen's School of Business as a Assistant Professor. Ajay Agrawal attended the University of British Columbia.

Investment focus

Hardware, Software, Textiles
Seed, Pre-Seed
Canada

Portfolio highlights

ALT TEX — ALT TEX is creating sustainable textiles regenerated from post-industrial waste.
EcoPackers — EcoPackers use the power of plants to create 100% biodegradable alternatives to traditional plastic inputs. Our eco-resins allow plastic manufacturers worldwide to create innovative non-toxic and compostable single use packaging items.
EZee Assist — EZee Assist provides instant answers to franchisee operational questions. Continue using preferred channels of support and start receiving instant answers and support.

Dr. Fong is a Professor Emeritus at the Faculty of Medicine, University of Calgary. He was formerly the Head of the Department of Radiology at the University of Calgary and the Calgary Health Region. Dr. Fong is active in funding and nurturing start-up companies. Over the past two decades, he funded over 50 companies in diverse technology sectors,with an emphasis in medical devices. Dr. Fong is the co-founder and board member of Calgary Scientific Inc. and is also on the board of Clarius Mobile Health, Cohesic Inc. and Innovere Medical. In addition to seed investing, Dr. Fong is active in the Calgary community sitting on six charitable boards and foundations.In 2015, Dr. Fong joined the Creative Destruction Lab (CDL) at the University of Toronto business school as a mentor. CDL helps young entrepreneurs to shape or pivot their nascent ideas. He is widely credited with launching CDL at the Haskayne School of Business at the University of Calgary, bringing together seasoned business leaders from Alberta, Canada and the US to grow budding companies. Dr. Fong is on the Strategic Advisory Board of CDL and a Fellow of CDL in Toronto, Montreal, Calgary and Vancouver. In 2017, Dr. Fong was named to the Order of Canada for his contribution to medical technology innovation and philanthropy.

Investment focus

Software, Artificial Intelligence, Biotechnology
Seed, Angel, Pre-Seed
Canada, Singapore, United States

Portfolio highlights

Oncoustics AI — Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers.
SunGreenH2 — SunGreenH2 creates the world's highest performance advanced materials for electrolysis i.e. green hydrogen production. Achieve high efficiency, low cost green H2 production on site for your application in the Power-to-X, Hydrogen refuelling, Energy Storage and Buildings sectors. Revolutionising zero emissions and improving profitability.
EZee Assist — EZee Assist provides instant answers to franchisee operational questions. Continue using preferred channels of support and start receiving instant answers and support.

Noel Hall is the Director of Corporate of Wellcome Trust. He is a former Board Director, Co-founder, and President of Aspreva Pharmaceuticals Corp. He attended the University of London.

Investment focus

Biotechnology, Genetics, Life Science
Seed, Angel
Canada, United States

Portfolio highlights

Epistemic AI — At Epistemic AI we are building the next generation of tools to accelerate biomedical research with AI and NLP.We are a group of senior scientists and engineers from the likes of Google, New York University, Stanford and more. We are dedicated to enabling advances in biomedical research and practice with AI and NLP.We are creating a movement ofpeople enthusiastically committed to a new vision for the future of biomedical research and we hope you want to join us.
Incisive Genetics — IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.

Investment focus

Hardware, Software, Textiles
Seed, Pre-Seed
Canada

Portfolio highlights

ALT TEX — ALT TEX is creating sustainable textiles regenerated from post-industrial waste.
EcoPackers — EcoPackers use the power of plants to create 100% biodegradable alternatives to traditional plastic inputs. Our eco-resins allow plastic manufacturers worldwide to create innovative non-toxic and compostable single use packaging items.
EZee Assist — EZee Assist provides instant answers to franchisee operational questions. Continue using preferred channels of support and start receiving instant answers and support.

Jacky is dedicated to angel investment and has built up a portfolio of more than thirty startup companies in Canada and the US. His target investments are the early-stage B2B companies with disruptive technologies and business potential in enterprise software, information technologies, MedTech, and Advanced Manufacturing.Jacky has acquiredconcrete business experiences as a successful founder in the startup ecosystem and an executive of Fortune 500 companies over two decades. His remarkable accomplishments range from building startups from scratch to leading a billion-dollar business with the leverage of 14,000 enterprise channel partners. The unique journey has shaped Jacky's outstanding of investing in early startups.Jacky holds the degrees of Mater's E.E. and MBA, and he graduated from CEIBS and The Wharton Business School of the University of Pennsylvania.

Investment focus

Software, Health Care, Information Technology
Seed, Pre-Seed, Funding Round
Canada, United States, China

Portfolio highlights

Workwolf — Workwolf is a Toronto-based start-up with a management team who has led 7 start-ups, had 2 successful exits, and has taken a company public with a $1.8B IPO. Workwolf CEO Erik Simins is an SME in HR who previously founded MAGNUS HRS, a staffing company now servicing over 150 enterprise customers. The technology at Workwolf solves two of the biggestpain points in employment: applicant filtration and verification, and does so by empowering users to identify better candidates faster. Winner of global awards in both 2020 and 2021 for innovation and market potential, Workwolf is ramping up for its multi-national roll-out with ManpowerGroup in September that will coincide with a $4.5M Seed financing round.
Agile Devices — Agile Devices offer catheter-based interventional procedures helping patients during a stroke. It helps medical practitioners reduce the procedure time to respond to time bound emergencies.
Traction Technology Partners — Traction is a powerful SaaS collaboration platform for evaluating, adopting and managing new technologies across the enterprise. The platform includes Project Management and CRM tools designed specifically for enterprise teams tasked with discovering and evaluating new technologies. Traction is used by IT, Innovation and Corp Dev teams toaccelerate their digital transformation projects, and to speed up the way they find, manage, and adopt new technologies. Traction also offers On-Demand Research services delivered through its platform.

Claudette is an award-winning Technology Leader with 17+ years of success leading digital transformation, optimizing infrastructure, designing new support approaches to improve service experience. She has led more than 600 IT professionals in the planning, engineering and support of workplace technologies across all BMO branches and office towers.Claudette began her IT career in healthcare at Wellesley Hospital. She later joined the Computing and Telecommunications Division at the Metropolitan Toronto Police Services. Before joining BMO, Claudette spent 4 years at Deloitte where she was a key member of the Technology Management Team.In 2008, Claudette founded Excelovate, a human services company designed to help people and enrich lives through the creation of new products and services. Her work has played a pivotal role in launching the first innovation centre in Aurora, Rap Riderz Innovation Centre.Married and a mother of two, Claudette's commitment to the community is evident in her passion for literacy and everything technological. Claudette has authored five books and in partnership with First Book Canada and other leading corporations, Claudette launched the Black Arts and Innovation Expo (BAIE) as a novel way to celebrate Black History Month. The BAIE promotes diversity and inspires excellence in Science, Technology, Engineering, Arts and Mathematics by showcasing the outstanding achievements of current innovators in the arts, entrepreneurship and technology.Claudette is a recipient of a 2014 Green4Good Visionary award and in 2015 she was hailed as a BBPA Exchange - Woman of Honor and among the Top 100 Black Women to watch in Canada.

Investment focus

Apps, Hospital, Software
Angel, Grant
Canada

Portfolio highlights

Areto Labs — Areto Labs is a human-focused cyber security company that uses AI to protect people by detecting and counteracting online abuse.
PragmaClin Research — PragmaClin Research Inc. is aiming to help patients monitor their symptoms faster with the use of our remote patient monitoring system, PRIMS (Parkinson's Remote Interactive Monitoring System).

Greg has a successful track record of bringing innovative solutions to the financial industry. In 1997 Greg co-founded 724 Solutions Inc., a wireless software infrastructure provider. He served as the company’s chief executive officer and led its IPO in 2000.In 1983 he founded Footprint Software Inc., a financial software company, which he sold toIBM in 1995. While at Footprint Software, Greg won the 1994 award for Canada’s Best Managed Private Company. In 1995 he won the award for Canada’s Top 40 Under 40 and in 2000 was named Entrepreneur of the Year.Greg holds a Bachelor of Arts in Computer Science from the University of Western Ontario and a double major, Biochemistry and Life Sciences from the University of Toronto.He sits on the boards of the Ontario Cancer Biomarker Network (OCBN); NoNo Inc., a company specializing in post stroke neuroprotection; and YYZ Pharmatech, which develops tools, targets, and biomarkers for pharmaceutical companies.

Investment focus

Internet, Software, Delivery
Seed, Series A
United States, Canada

Portfolio highlights

Nymi — Nymi provides a new paradigm for connecting people to their workplace on a platform, which streamlines work securely across different networks and environments. Passwordless, contactless, handsfree.
PasswordBox — Say goodbye to the hassle of passwords
Vantage — Vantage Analytics offers today’s leading online business managers a collection of powerful predictive analytics and data mining modules, served up in an accessible interface that makes data excitingly easy to work with.To make it easy to import and export your data, they have integrated connections into the most common online business services:shopping carts, web analytics and more. Just as importantly, they allow you to take immediate action through leading marketing automation tools and business apps.Vantage will inspire, guide, and support powerful marketing strategies. Leverage new customer insight to easily send targeted campaigns over email, Facebook, Twitter, Instagram, and Pinterest.Monitor campaign progress and optimize in real-time.They offer their platform on a software-as-a-service basis: Use and pay for only what you need, the rest will be ready when you are.

Lee Lau is a Partner and Co-Founder of Alignvest Management Corporation. Mr. Lau co-founded ATI Technologies in 1985 and built the company into one of the world’s largest supplier of graphic chips and add-in boards to the personal computer industry. In addition to managing the company, Mr. Lau was ATI’s largest shareholder, first employee andresponsible for innovation and development of all products. Mr. Lau helped build ATI into a TSX and NASDAQ listed global market leader, with annual sales in excess of $2.2 billion and over 3,000 employees. ATI was sold in 2006 to Advanced Micro Devices for cash and stock consideration of $5.3 billion. Since then, Mr. Lau has managed his family office investing in a variety of alternative asset products. Prior to founding ATI, Mr. Lau held various design engineering positions with Mitel, Motorola and Plessey.Mr. Lau holds a Masters in Engineering and a BASc from the University of Toronto.

Investment focus

Wearables, Software, Internet of Things
Seed, Convertible Note
Canada

Portfolio highlights

Nymi — Nymi provides a new paradigm for connecting people to their workplace on a platform, which streamlines work securely across different networks and environments. Passwordless, contactless, handsfree.
Lumotune — We are creating a platform to transform the world’s glass into digital displays.
Springdel — Move beyond cloud and legacy MDM with an enterprise-grade EdgeOps platform purpose-built for the interactive Edge of Things.

Ran Tuttnauer

Investment focus

Health Care, Big Data, Medical Device
Seed, Series A
Israel, Canada, United States

Portfolio highlights

Innovopro — Bringing a unique chickpea protein platform to the global food & beverage market, for creating nutritious, tasty, and sustainable food products.
Solidify — The Marketplayz platform helps you find the perfect creators to promote your products. It utilizes AI-powered technology to enable advertisers and creators to connect through a one-stop, self-service marketplace.
Geneyx — Geneyx offers a superior NGS data analysis and interpretation platform, Harnessing genetic data to guide digital insights for rare and germline disorders Geneyx

Paul Buchheit co-founded social network aggregator FriendFeed, along with three other former Google employees. He is also an investor in FriendFeed and participated in a $5 million Series A round in February 2008.He was the 23rd employee at Google, where he created Gmail and implemented many of its innovative features. He developed the originalprototype of Google AdSense, and was responsible for Google's famous "Don't be evil" motto in a meeting.

Investment focus

Software, Health Care, E-Commerce
Seed, Series A, Angel
United States, Canada, India

Portfolio highlights

SiPhox Health — SiPhox offers a handheld testing device with RNA/DNA and protein testing for point-of-care and At-Home solutions. The company's kit is made by multiplexing RNA, antibody, and antigen tests on a single silicon photonic chip which is amplified by plasmon resonance and silicon photonic resonator readout, enabling users to undertake tests fordisease safely and in a disposable point-of-care and at-home manner.SiPhox was founded in 2020 and is based in Cambridge, Massachusetts, USA.
Character.ai — Meet AIs that feel alive. Chat with anyone, anywhere, anytime. Experience the power of super-intelligent chat bots that hear you, understand you, and remember you.
Perplexity AI — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.

Dan Schultz

Investment focus

SaaS, Data Mining, Life Science
Seed
Canada, United States

Portfolio highlights

Prospectify — #1 trusted site to buy youtube subscribers India. Offer high quality, safe and legit buy youtube subscribers cheap prices and order starts in 24-48 Hrs
Propellon Therapeutics — Propellon Therapeutics is developing and commercializing novel cancer therapies targeting the WDR5 protein, essential for assembly of methyltransferase complexes and proper histone modification. The overexpression of WDR5 and resulting deregulation of epigenetic mechanisms are implicated in various cancers and correlated with poor patient survival.Established by FACIT, Propellon’s WDR5 inhibitor platform arises from discoveries, research and innovations originating from OICR.

Dr. Milad Alucozai is an Afghan-American neuroscientist, entrepreneur, biotech executive, and global investor with nearly two decades of experience in deep tech, primarily in life sciences. He pushes the boundaries of bioengineering and computational advancements, integrating machine learning and artificial intelligence into biology and medicine.With a strong commitment to commercializing transformative technologies and fostering startup ecosystems worldwide, he is a thought leader and formal mentor for entrepreneurs through organizations like Creative Destruction Lab and the Wyss Institute at Harvard Medical School.Currently, Milad is the head of Bio and Deep Tech at BoxOne Ventures, where he spearheads the firm’s investments in early-stage companies with breakthrough scientific ideas. With nearly 80 early-stage investments, they are recognized as one of North America’s most active venture firms. He is also a Venture Partner at Entrepreneur First, a global fund that has built over 500 companies from scratch with an enterprise value of $10bn. He supports founders with strategy, scaling, business development, securing growth capital, and leadership training, often being their first investor and guiding them from startup inception to IPOs or acquisitions.He started his career in translational neuroscience and multiphysics laboratories before transitioning into founding roles at biotech startups. He is part of the founding team at Mekonos, a San Francisco-based company creating a proprietary cell-engineering platform to support the future of cell and gene therapies. He was also part of the founding team at Corstem, which specialized in machine learning and artificial intelligence software and was later acquired by Circle Cardiovascular, a platform in over 1000 hospitals and more than 40 countries. At Accenture, Milad directed teams of data scientists, designers, and engineers in developing artificial intelligence platforms for global pharmaceutical companies and hospital networks.Milad serves as a Fellow in Healthcare Engineering at the Regenstrief Center. In 2020, he served as an External Advisor to AstraZeneca. He was recognized as a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed his master’s in Immunology and earned his doctorate from the Richard M. Fairbanks School of Public Health.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Pre-Seed
United States, Canada, United Kingdom

Portfolio highlights

Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.

Nilesh is co-founder and CTO of Aislelabs and he leads the product development and engineering. Before Aislelabs, Nilesh co-founded Sysomos in 2007. Sysomos went on to become the most advanced social media analytics platform of its kind, serving 70% of the Fortune 50 enterprises, and was later acquired in 2010. Nilesh is also an angel investorand advisor to a number of startups and incubators including Extreme Startups, MaRS Jolt, Bionym, and Granify. Nilesh has significant experience in building robust and scalable software systems, data management platforms and big data analytics solutions. Nilesh's work has appeared in leading research forums worldwide.Nilesh holds a PhD, Computer Science from the University of Toronto, and a B.Tech. Computer Science and Engineering from the Indian Institute of Technology (IIT) Bombay.

Investment focus

SaaS, Big Data, Hardware
Seed
Canada

Portfolio highlights

Nymi — Nymi provides a new paradigm for connecting people to their workplace on a platform, which streamlines work securely across different networks and environments. Passwordless, contactless, handsfree.
Granify — Granify is an e-commerce conversion and revenue optimization technology powered by machine learning that regularly brings top retailers 3%-5% uplift.

Fred has served as our Chief Executive Officer since April 2016. As CEO, he has led the transformation of IMV into a leading clinical-stage immune-oncology company with world-class collaborators and a strong scientific foundation. He has more than 21 years of experience in the biopharmaceutical industry, having served in several managementpositions encompassing business development, intellectual property, strategic planning, pre-marketing, and communication. Before joining IMV, Fred spent 14 years at Medicago serving in many roles of increasing responsibility, most recently as Vice President of Business Development and Strategic Planning. He had been an integral part of Medicago’s success, including securing more than $300M CAN in non-dilutive funding in revenues and future milestones from licensing agreements and government contracts, and the $357M CAN deal acquisition by Mitsubishi Pharma in 2013.Fred is also a Director of CQDM, a biopharmaceutical research consortium and served as second Vice-Chair of the Vaccine Industry Committee of Biotech Canada between 2012 and 2016. Prior to Medicago, Fred was Licensing Manager at the University Paris VII-Denis Diderot, one of the largest sciences and medical university in France. He owns a BSc degree in Biology and a Master’s degree in Biotechnology and Business Management from the University of Angers (France).

Investment focus

Medical, Health Care, Biotechnology
Seed
Canada

Portfolio highlights

Saguaro Technologies — Saguaro Technologies offers innovative cell culture products that help scientists work with in vitro models that are more predictive of results in clinical trials with humans.

Haig Farris is one of Canada's best-known venture capitalists and experts in high-technology start-ups and turn-arounds, with a varied 30+ year history of involvement, commitment, and management. He has a law degree from the University of Pennsylvania. He is co-founder and former Executive Chair of the Board of Directors of D-Wave, and he isthe President of Fractal Capital, a private venture capital company financing high technology start-ups and resource service technology companies.Previously, Dr. Farris was a co-founder and partner of the Ventures West Management group of venture capital funds (1972-1990). In 2001, he received the British Columbia Technologies Industry Association's (BCTIA) Bill Thompson Award.He was awarded an Honorary Doctor of Laws degree from UBC in 1997 and named A Pioneer of Innovation by the Vancouver Board of Trade in 2001.

Investment focus

Biotechnology, Genetics, Life Science
Seed, Pre-Seed
Canada, United States

Portfolio highlights

Epistemic AI — At Epistemic AI we are building the next generation of tools to accelerate biomedical research with AI and NLP.We are a group of senior scientists and engineers from the likes of Google, New York University, Stanford and more. We are dedicated to enabling advances in biomedical research and practice with AI and NLP.We are creating a movement ofpeople enthusiastically committed to a new vision for the future of biomedical research and we hope you want to join us.
Incisive Genetics — IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.

Sandra MacPherson

Investment focus

Genetics, Biotechnology, Medical Device
Seed
Canada

Portfolio highlights

Incisive Genetics — IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.

Dennis Bennie is a pioneer, entrepreneur and innovator in the Canadian technology industry. Over the past 20 years, Bennie's entrepreneurial management has powered Mission Electronics, Ingram Canada and Delrina. In 1997, he founded the XDL Venture Capital Fund, focusing on information technology opportunities. The $25 million fund hasyielded exceptional returns to date. One of its most noteworthy investments was a 1997 start-up, Delano Technology Corporation (NASD:DTEC). XDL Intervest, a $150 million fund was started in 1999 and is now fully invested. Bennie currently manages an experienced team investing in private equity opportunities as the XDL Capital Group. From 1988 to 1996, Mr. Bennie was CEO of Delrina Corporation, an independent software developer and publisher, which forged the new software categories of electronic forms and PC fax communications. Under Mr. Bennie's leadership, Delrina pioneered the development of PC fax software called WinFax and became a world leader in the communication software market with annual sales revenue exceeding $130 million. Listed on both the Toronto Stock Exchange and NASDAQ, Delrina cultivated a reputation for leadership, growth and profitability, and completed several public offerings. In November 1995, the company was successfully sold to Symantec Corporation for share consideration valued at $560 million. Mr. Bennie entered the world of technology in 1979, when he co-founded Mission Electronics. He drove the expansion of this leading British audio equipment manufacturer to become a dominant force in the high-end stereo market. In 1982 he sold his interest in Mission Electronics and founded Aviva Software, an independent, mass-market software developer. Under his direction, the company expanded its scope to include software distribution and merged with Ingram Micro Inc. in 1986 to become Canada's largest software distributor. Residing in Toronto, Canada, with his wife Laura and three daughters, Dennis is an avid golfer and runner. A member of the World President's Organization, he also regularly serves on various charitable boards including the Toronto Hospital Board.

Investment focus

Software, Artificial Intelligence, Internet of Things
Seed, Pre-Seed, Series A
Canada, United States

Portfolio highlights

Delphia — Invest with your data, not your money.
Tread — Tread's construction fleet management software makes the business of moving construction materials easier and more profitable. Request a demo today!
Thriver — Discover, book, and manage workplace culture services and employee experiences all in one place. Empower your team with effective employee engagement activities.

blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.

Investment focus

Health Care, Biotechnology, Software
Seed, Series A, Pre-Seed
United States, Canada, India

Portfolio highlights

Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement

Prior to Maginatics, Amarjit co-founded and helped lead three companies that built lasting technologies. He was co-founder and VP of business development and sales at SiByte (acquired by Broadcom), co-founder and EVP of business development and sales at PA Semi (acquired by Apple), and co-founder and CEO of Agnilux (acquired by Google).Earlierin his career, Amarjit was director of sales for strategic accounts in Digital Equipment Corporation’s semiconductor group. After that business unit was purchased by Intel, he served in a similar capacity for Intel. Amarjit also worked for many years at Texas Instruments in its technical sales organization.Amarjit received a BS degree in Electrical Engineering from San Jose State University.

Investment focus

Artificial Intelligence, Biotechnology, Information Technology
Seed, Convertible Note, Series A
United States, Canada

Portfolio highlights

Asato — Asato is developing an AI-powered enterprise copilot platform for CIOs, giving unprecedented visibility and control over AI-powered IT spending and empowering to take decisive action.
Alcion — Secure, intelligent, and intuitive backups for Microsoft 365. Delivered as a modern AI-driven SaaS platform.
Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with ArteraAI. Transforming cancer therapy through innovation.

Lip-Bu Tan is Chairman and Founder of Walden International and has been active in the venture capital industry for the past two decades. Additionally, he introduced and pioneered the U.S. venture capital concept in Asia and contributed towards the promotion of early-stage technology investing in the Asia-Pacific region.Prior to WI, he was VicePresident at Chappell & Co. and held management positions at EDS Nuclear and ECHO Energy. Mr. Tan concurrently serves as President and Chief Executive Officer of Cadence Design Systems, Inc. and has been a member of the Cadence Board of Directors since 2004.He is also a board member of Flextronics (NASDAQ: FLEX), SINA (NASDAQ: SINA), SMIC (NYSE:SMI / HKSE:981), a member of the VC Advisory Board of Global Semiconductor Alliance (GSA), serves on the College of Engineering Advisory Board at University of California Berkeley, the School of Engineering Dean's Council at Carnegie Mellon University (CMU), the School of Engineering Dean's Advisory Board and the Visiting Committee for the Department of Electrical Engineering and Computer Science at the Massachusetts Institute of Technology (MIT), a trustee of Nanyang Technological University in Singapore, and a member of the Committee of 100.He also served as a member of the Board of Trustees of the University of San Francisco for 9 years.He holds a B.S. in Physics from Nanyang University in Singapore, an M.S. in Nuclear Engineering from Massachusetts Institute of Technology, and an M.B.A. from the University of San Francisco.

Investment focus

Software, Semiconductor, Artificial Intelligence
Series B, Seed, Series A
United States, Israel, China

Portfolio highlights

Asato — Asato is developing an AI-powered enterprise copilot platform for CIOs, giving unprecedented visibility and control over AI-powered IT spending and empowering to take decisive action.
SiMa.ai — SiMa.ai™ is a machine learning company transforming the embedded edge market through high-performance compute at the lowest power. Initially focused on computer vision applications, the company’s software-first approach simplifies ML integration and supports the broadest set of capabilities through a purpose-built MLSoC™ platform, enabling rapidadoption and creating the best of ease-of-use experience. SiMa.ai is led by technologists and business veterans and backed by a set of top investors committed to helping customers scale machine learning at the edge.
Guardrails AI — Enforce assurance for LLM applications

Nick is a co-founder and CEO at Aislelabs. Before Aislelabs, Nick co-founded Sysomos, a leading provider of social media analytics. Sysomos is used by enterprise users and digital marketers around the globe, including 70% of the Fortune 50 companies.Nick is also on the faculty at the University of Toronto's computer science department. Heholds several patents, and has published more than 100 research publications in the areas of big data analytics, information mining and searching. Nick serves on the editorial review boards of several international scientific journals in field of data management. Prior to joining the university, he was a member of AT&T's research staff.Nick is an active angel investor and mentor to several startups, including at the Creative Destruction Lab at the Rotman School of Business. Nick holds a PhD from the University of Toronto.

Investment focus

SaaS, Big Data, Hardware
Seed
Canada

Portfolio highlights

Nymi — Nymi provides a new paradigm for connecting people to their workplace on a platform, which streamlines work securely across different networks and environments. Passwordless, contactless, handsfree.
Granify — Granify is an e-commerce conversion and revenue optimization technology powered by machine learning that regularly brings top retailers 3%-5% uplift.

Lawrence Bloch, M.D., J.D. is the former President of Infinity. He joined the company as chief financial officer and chief business officer in 2012 and has played a key role in developing and executing the company’s corporate and financial strateBeforeior to joining Infinity in 2012, Dr. Bloch served as chief executive officer of NeurAxon, Inc., acompany focused on developing next-generation pain therapeutics, from 2007 to 2011. Previously, he served as chief business officer and chief financial officer of NitroMed, Inc., raising $150 million in equity and $20 million in venture debt to support the commercial launch of BiDil®. From 1999 to 2004, he served as chief financial officer and vice president of business development of Applied Molecular Evolution, Inc., leading the company’s $101 million initial public offering and $420 million merger with Eli Lilly and Company.Dr. Bloch began his career as an emergency medicine resident physician at Massachusetts General Hospital and Brigham & Women’s Hospital. He holds a J.D. from Harvard Law School, an M.D. from Harvard Medical, School, and an MBA from Harvard Business School.

Investment focus

Neuroscience, Therapeutics, Biotechnology
Series B, Debt Financing
Canada

Portfolio highlights

NeurAxon — NeurAxon, Inc. discovers and develops pain therapeutics targeting neuronal nitric oxide synthase. It has oral products in pipeline addressing acute migraine, neuropathic pain chronic daily headache, inflammatory pain, migraine prophylaxis, and severe pain. The company was founded in 2004 and is headquartered in Toronto, Canada.

Jed McCaleb is a Board Member and Advisor to the CEO. He is the founder of the Astera Institute, which is dedicated to improving the process of science. He also co-founded the Stellar Development Foundation and created eDonkey2000, one of the largest file-sharing networks in its time. His favorite organisms are the aliens among us, the octopus.

Investment focus

IT, Payments, Software
Seed, Initial Coin Offering
United States, Canada

Portfolio highlights

Socket — Secure your JavaScript supply chain. Depend on Socket to protect your app from malicious dependencies lurking in your open source supply chain.
Stream Token — Stream is a new decentralized blockchain-based token that allows livestreamers to easily and anonymously accept payments from their audience members anywhere in the world, with extremely low transaction fees and no platform lock-in.
Propellon Therapeutics — Propellon Therapeutics is developing and commercializing novel cancer therapies targeting the WDR5 protein, essential for assembly of methyltransferase complexes and proper histone modification. The overexpression of WDR5 and resulting deregulation of epigenetic mechanisms are implicated in various cancers and correlated with poor patient survival.Established by FACIT, Propellon’s WDR5 inhibitor platform arises from discoveries, research and innovations originating from OICR.

Wei Guo, the founding partner of UpHonest Capital, is an active angel investor in Silicon Valley, focusing on early-stage cross-sector investments. He founded Wei Fund in 2015 and UpHonest Capital Fund I in 2016, invested in well-known companies such as Hims&Hers(NYSE: HIMS), Vicarious Surgical(NYSE: RBOT), Knightscope (NASDAQ: KSCP), Checkr,Lime, Boom, Rescale, Dialpad and more. Since 2015, he has invested in over 400 Silicon Valley startups, over 76 companies with valuations greater than 100 million USD, and 23 portfolio companies that have successfully exited.

Investment focus

Software, Artificial Intelligence, Health Care
Seed, Series A, Angel
United States, China, Canada

Portfolio highlights

Golden — Golden is a developer of a self-constructing knowledge database used to accelerate discovery and education. The company uses and leverages human effort by using machine intelligence to make the process of gathering and communicating knowledge simpler.It combines a powerful search across several entities with fine-grain alerts to stay on top ofchanges, and semi-automatic research assistance for gaps in knowledge that enable people in organizations to stay current, understand and leverage the latest trends in their industry.
Playbook — Playbook gives creators the opportunity to build and grow a subscription business. Fans get an all-access pass to a curated health and wellness content.
Crossing — Crossing Media is a live broadcast e-commerce service company that builds awareness, engagement, and sales through live-stream shopping.

Ryan Pawell (Founder, Director & Chief Executive Officer) is a Y Combinator alumni, published author and subject matter expert in the areas of fluid dynamics, advanced manufacturing, and biomicrofluidics. Ryan has been invited to present his work by the Australian National Fabrication Facility, White House Cancer Moonshot Taskforce, Air Force,National Institutes of Health, and National Cancer Institute among others.

Investment focus

Medical, Biopharma, Biotechnology
Seed
Canada, United States

Portfolio highlights

Pioneer Fund — 300+ YC alumni investing in the top YC startups
Avro — Avro Life Science is developing skin patches for generic drug delivery, focusing on therapeutics for children and the elderly. The core of our technology is a novel biopolymer which is used as a platform for passive transdermal drug delivery of small molecules and drugs.

Daniel is the Vice President of Product (Demand) at Shopify. He previously worked as an SVP at Salesforce.com, where he drives marketing for Salesforce Work.com, a sales performance management solution that helps Facebook, LinkedIn, Spotify, and other innovative companies align, motivate, and drive the performance of their sales teams. Prior tojoining Salesforce, Daniel was co-founder and co-CEO of Rypple, a social performance management platform acquired by Salesforce in 2012. Prior to Rypple, Daniel was on the founding team of Workbrain, which provided workforce management solutions to Wal-Mart, Citibank, and other large enterprises. Workbrain grew to $100 million in annual revenues before being acquired by Infor in 2007.A sought after speaker on how social media is changing the workplace, Daniel is a contributor to Fortune.com and the Huffington Post. He’s been widely quoted in Wired, the Financial Times, the Economist and Bloomberg Businessweek. Daniel holds a JD/MBA from the University of Toronto and an LLM in Law, Science and Technology from Stanford University.

Investment focus

Software, Artificial Intelligence, Enterprise Software
Seed, Series A, Pre-Seed
Canada, United States

Portfolio highlights

Shakepay — Shakepay allows Canadians to buy/sell bitcoin and pay their friends. We're on a mission to create open access to building wealth.
Spatial — Experience virtual NFT art exhibitions, meetups, and live events together with lifelike avatars. Customize beautiful 3D spaces. Join now from Web, Mobile, & VR.
Haloo — Protect your brand from day one. We help small businesses like yours run affordable legal searches and prepare for trademark registration.

Jeffrey Mallett was most recently the Chairman of SNOCAP, and has a rich history and proven experience in growing technology companies. As president and chief operating officer for Yahoo Inc. from 1995-2002, Mallett helped drive extraordinary growth and success for the company while simultaneously serving as an elected member of the Board ofDirectors. Mallett joined Yahoo in 1995, when the private company consisted of 12 employees and had no revenue. He helped the company go public in 1996, and during his seven year tenure, Mallett helped build Yahoo into one of the most recognizable entertainment and media brands in the world. By 2002, Mallett managed a global workforce of 4,000 employees in 27 countries, with $1 billion in revenue, and had overseen more than 20 acquisitions for the company. Mallett is currently an owner and executive committee member of the San Francisco Giants. Prior to his tenure at Yahoo, Mallett was vice president and general manager of the consumer products division of Novell, Inc. and a member of Novell's global marketing board, where he was involved with the merger of Novell and WordPerfect Corp. in 1994. He was a founding executive team member and vice president of Reference Software, an independent worldwide leader in consumer software language services, and led the company to a successful acquisition by WordPerfect in 1992. He also served as director of the Canadian-based telecommunications company Island Pacific Telephone, where Jeff drove the start-up's growth and development until it was acquired by telecommunications giant Cable and Wireless in 1987. Mallett lives in the San Francisco Bay Area with his wife of 19 years and their two children.

Investment focus

Media and Entertainment, E-Commerce, iOS
Funding Round, Angel, Series A
Canada, United States

Portfolio highlights

Gametime — Gametime sells last-minute tickets to the most popular events in sports, music, and theater. It makes finding the perfect live experience remarkably fast and easy. They curate an epic list of the most amazing possibilities in the city has to offer. Once the client selects their event it will examine over 10,000 potential seats and present them withthe 50 best values to select.Each curated seat option includes a panoramic high-resolution photo so their client can experience the actual view from their section. Navigate to the seat map to see price versus the location comparisons with true-to-life, full-color venue maps. Gametime delivers the tickets directly to the client's phone. Now they are offering sports, concerts, and theater events across the United States and Canada.
Ananda Devices — High throughput microfluidic devices to accelerate drug development in neuroscience.
Caravan Digital Studios — At Caravan, entrepreneurship runs deep. We are pioneers in the celebrity-founded model of company creation. We pride ourselves on diving into product categories that are often overlooked or untouched and creatively solving real consumer problems. Our team excels at leveraging proprietary data and reach to identify unique opportunities and build authentic brands with an immediate audience. Our extensive experience co-founding, operating and investing in companies allows us to serve as trusted partners to the artists we co-create with.

Collin Terpstra is an allergy specialist.

Investment focus

Health Care, Biotechnology, Science/Engineering
Series A
Canada

Portfolio highlights

Kenota Health — Kenota Health develops next-generation rapid point-of-care system intended to be used for allergy testing in humans. Kenota's diagnostic tools are safe, simple, and offer a cheaper alternative to allergy testing using a thorough non-invasive technology, enabling physicians to improve patient outcomes.

Jon Oringer is the founder and chairman of Shutterstock.

Investment focus

Software, Information Technology, E-Commerce
Seed, Pre-Seed, Funding Round
United States, France, United Kingdom

Portfolio highlights

Skedway — Every work experience should be great! Skedway is the complete platform to optimize the hybrid work experience.
Zamp — We give you freedom from sales tax! Eliminate the need to learn, manage or touch any part of the sales tax compliance process.
NewHomesMate — Find, compare and buy a new construction home - all in one place.

Rami Essaid is the Co-Founder and Chief Executive Officer of Finmark, a Venture Partner at IDEA Fund Partners, and an Extended Team Member of Ubiquity Ventures. He was the Co-Founder and Chairman of Distil. Rami helps enterprises embrace the cloud to improve their scalability and reliability while maintaining a high level of security.He attendedNorth Carolina State University where he majored in computer engineering.

Investment focus

Software, Data and Analytics, Sales/Marketing
Seed
United States

Portfolio highlights

Prospectify — Best Site to Buy Twitch Followers, Buy Twitch Views, Buy Channel Views, Live Views & Clip Views @ Best Price With 24x7 Support.
Propellon Therapeutics — Propellon Therapeutics is developing and commercializing novel cancer therapies targeting the WDR5 protein, essential for assembly of methyltransferase complexes and proper histone modification. The overexpression of WDR5 and resulting deregulation of epigenetic mechanisms are implicated in various cancers and correlated with poor patient survival.Established by FACIT, Propellon’s WDR5 inhibitor platform arises from discoveries, research and innovations originating from OICR.

Shaz Khan is the Chief Strategy Officer/Co-Founder at Vroozi

Investment focus

Hardware, Biometrics, Health Care
Debt Financing
Canada

Portfolio highlights

OMsignal — Omsignal manufactures bio-sensing clothing that connects to iPhones and iPads in real-time. Embedded sensors in the apparel monitor heart rate, breathing, and activity while the Omsignal app displays data in real-time on a mobile phone. OMsignal fits seamlessly into everyday life. It was founded in 2011 and is headquartered in Montréal, Canada.

Carol Leaman is the CEO of Axonify Inc., a Waterloo-based next generation eLearning company that combines gamification with brain science to revolutionize the way companies think about and deliver training to employees.Axonify makes learning stick with personalized, bite-sized information delivered in a fun, rewarding way that drives real learningtransfer and is saving companies millions. Carol won the Fortune Brainstorm Tech Pitch Competition in July 2012 against 4 other early stage technology companies garnering Axonify worldwide recognition as an emerging leader in the eLearning space.Prior to forming Axonify, Carol was the CEO of PostRank Inc. a social media engagement platform company that she sold to Google in June 2011. Carol is a serial entrepreneur and a Chartered Accountant who has been running and advising early stage technology companies for almost 15 years.

Investment focus

Health Care, Hospital, Neuroscience
Seed, Angel, Series A
Canada

Portfolio highlights

KeyOps — A revolutionary physician engagement platform that allows doctors to quickly share their expert opinions with healthcare stakeholders such as government institutions, hospitals, universities, and life science companies.
Trusscore — Trusscore is changing residential and commercial construction with products that combine sustainable materials with nanotechnology. Our PVC-based wall and ceiling panels are easy-to-install and high-performance replacements for traditional drywall and fiber-reinforced plastic panels.
PragmaClin Research — PragmaClin Research Inc. is aiming to help patients monitor their symptoms faster with the use of our remote patient monitoring system, PRIMS (Parkinson's Remote Interactive Monitoring System).

Investors by industry

Media (entertainment)

EdTech

Consumer

Climate